Burtness, B., Tao, Y., Siu, L. L., Licitra, L. F. L., Tahara, M., Rischin, D., Alves, G. V., Lima, I. P. F., Hughes, B. G. M., Pointreau, Y., Aksoy, S., Laban, S., Burian, M., Hetnał, M., Delord, J., Kassalow, L., Bidadi, B., Benjamin, K. T., Machiels, J. (2026). PD-L1 CPS ≥10 population subgroup analysis of KEYNOTE-412: Pembrolizumab plus chemoradiotherapy versus placebo plus chemoradiotherapy for unresected locally advanced head and neck squamous cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6063